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Materials and Methods 
Experimental protocol 
The DEX experiment was performed as a two-way cross-over design, each group containing three 
4-week-old broiler chickens and with a wash-out period of 96 hours. The animals received a bolus 
of 0.3 mg/kg body weight DEX-sodium phosphate (DEXA 0.2%®, Kela Laboratories, see Fig. 2B) 
intravenously (IV) in the wing vein or intramuscularly (IM) in the pectoral muscle. Blood (1 ml) 
was sampled by venipuncture from the leg vein before (time 0) and post-administration (0.25, 
0.5, 0.75, 1, 2, 4, 6, 8, 10, 12 and 24 hours). Plasma was stored at ≤ -15°C until analysis.  
 
DEX analysis 
Quantitation of the active form of DEX (Fig. 2A) in plasma was carried out using a liquid 
chromatography-tandem mass spectometry (LC-MS/MS) method. This is shown in Fig 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Diagram of DEX analysis using a             Figure 2. Chemical structures of DEX (A) and 
LC-MS/MS method                                     the ester prodrug, DEX-sodium phosphate (B) 
 
PK and Statistical analysis 
The PK parameters were analyzed using WinNonlin, version 6.2.0 (Pharsight). A one-
compartmental model was used to determine AUC0∞, kabs and kel, T1/2abs and T1/2el (expressed as 
the harmonic mean), Vd, Cl, C0, Cmax and Tmax.  
The absolute bioavailability (F) was calculated from the following equation:  
F (%) = (AUC0∞ IM / AUC0∞ IV ) × 100 
The data were statistically analysed by means of single-factor analysis of variance (ANOVA), 
using PASW Statistics 18 (IBM SPSS software). A value of P<0.05 was considered significant. 
Parameter Units IV IM 
AUC0∞ h.ng/mL 233.42 ± 73.04 277.09 ± 70.33 
kabs /h - 6.70 ± 3.57 
kel /h 1.52 ± 0.37 0.99 ± 0.22
* 
T1/2abs h - 0.10
A ± 0.045 
T1/2el h 0.46
A ± 0.10 0.70A ± 0.10* 
Vd L/kg 0.93 ± 0.27 1.17 ± 0.26 
Cl L/h.kg 1.38 ± 0.40 1.14 ± 0.25 
Tmax h - 0.37 ± 0.11 
C0 ng/mL 348.17 ± 109.80 - 
Cmax ng/mL - 185.85 ± 0.035 
F % - 122.95 ± 28.29 
Results 
The semi-logarithmic plots of the plasma concentration-time curves after IV and 
IM administration are depicted in Fig. 3. 
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Discussion and Conclusion 
The very fast elimination of DEX and a phase of simultaneous absorption and elimination after 
the IM administration, resulted in a significant difference between the IV and IM T1/2el, although a 
flip-flop phenomenon did not occur (kabs > kel). Similarly to many other species, the Vd of DEX in 
chickens is ~1 L/kg BW. Accordingly, the short T1/2el is due to the high clearance, as the clearance 
is inversely proportional to T1/2el. Chickens cleared DEX considerably faster than mammalian 
species, which can be related to higher metabolic rates in birds compared to mammals. 
 
We can conclude that there is a complete and fast absorption as well as a fast 
elimination of the active substance of DEX-sodium phosphate following IM 
administration in broiler chickens. 
 
In the future, DEX will be tested in a LPS-inflammation model in 
broilers. The pharmacokinetics here presented will be useful in 
this pharmacodynamic model. DEX might have also the ability to 
suppress the acute phase response by decreasing the pro-
inflammatory cytokines and acute phase proteins in poultry and 
maybe to reduce changes in body temperature. 
Figure 3. Mean (±SD) plasma concentration-time profiles of dexamethasone 
after IV and IM bolus administration of 0.3 mg/kg BW in broiler chickens (n=6) 
Table 1. Pharmacokinetic parameters for dexamethasone in broiler chickens 
after IV and IM bolus administration of 0.3 mg/kg BW (n=6, mean ±SD) 
A: harmonic mean 
*: significant difference (P<0.05) 
Introduction 
Dexamethasone (DEX) is a synthetic derivate of cortisol and is one of the most potent glucocorticoids in man and animal. The pharmacokinetics of this active substance are well known 
in many mammalian species. In poultry, however, data on the disposition of DEX are absent.  
DEX would be a possible candidate-drug to influence mediators like cytokines and acute phase proteins in a lipopolysaccharide (LPS) inflammation model. First of all, it is important to 
determine the pharmacokinetics to investigate the immunomodulating properties of this drug. Therefore the aim of this study was to investigate several pharmacokinetic (PK) 
parameters, i.e. area under the curve, AUC; absorption and elimination rate constant, kabs and kel; half-life of absorption and elimination, T1/2abs and T1/2el; volume of distribution, Vd; 
clearance, Cl; maximum plasma concentration at 0 h, C0; maximum plasma concentration, Cmax; time to Cmax, Tmax and absolute bioavailability, F, of DEX in broiler chickens.  
